IS6779A
Humanized anti-lt-beta-r antibodies
Abstract
Humanized antibodies to LT- beta -R and method of use thereof are provided.
Term
Term ended
Projected expiry passed 11 April 2023, 3.5 years ago.
- Priority
- Filed and published
- Projected expiry
- Today
99 members in 30 offices
Priority claims13
| Document | Office | Kind | Date |
|---|---|---|---|
| 24028500 | United States of America | P | |
| 24028500 | United States of America | P | |
| 27528901 | United States of America | P | |
| 27528901 | United States of America | P | |
| 29998701 | United States of America | P | |
| 29998701 | United States of America | P | |
| 0132140 | United States of America | W | |
| 0132140 | United States of America | W | |
| PCTUS0132140 | – | – | – |
| US20000240285P | – | – | – |
| US20010275289P | – | – | – |
| US20010299987P | – | – | – |
| WO2001US32140 | – | – | – |
Members99
| Document | Office | Kind | |
|---|---|---|---|
| CA2425809A1 | Canada | A1 | |
| WO0230700A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0230986A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1174702A | Australia | A | |
| AU1321002A | Australia | A | |
| WO0233529A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO0233673A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1320902A | Australia | A | |
| AU2437402A | Australia | A | |
| WO0234571A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2437302A | Australia | A | |
| WO0239761A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3765002A | Australia | A | |
| US2002091473A1 | United States of America | A1 | |
| WO0239761A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0233529A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0233673A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0234571A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002116156A1 | United States of America | A1 | |
| US2002120371A1 | United States of America | A1 | |
| US2002120374A1 | United States of America | A1 | |
| WO0230700A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002151297A1 | United States of America | A1 | |
| WO0230700A8 | World Intellectual Property Organization (WIPO) | A8 | |
| WO0230986A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20031642D0 | Norway | D0 | |
| IS6779AThis record | Iceland | A | |
| KR20030041164A | Republic of Korea | A | |
| NO20031642L | Norway | L | |
| US6580973B2 | United States of America | B2 | |
| KR20030055282A | Republic of Korea | A | |
| KR20030059193A | Republic of Korea | A | |
| EP1326759A2 | European Patent Office (EPO) | A2 | |
| EP1326897A2 | European Patent Office (EPO) | A2 | |
| EP1328421A2 | European Patent Office (EPO) | A2 | |
| EP1328857A2 | European Patent Office (EPO) | A2 | |
| EP1329116A2 | European Patent Office (EPO) | A2 | |
| EP1330377A2 | European Patent Office (EPO) | A2 | |
| KR20030064765A | Republic of Korea | A | |
| EE200300179A | Estonia | A | |
| KR20030070888A | Republic of Korea | A | |
| KR20030070889A | Republic of Korea | A | |
| SK5672003A3 | Slovakia | A3 | |
| CZ20031307A3 | Czechia | A3 | |
| HU0302573A2 | Hungary | A2 | |
| EA200300464A1 | Eurasian Patent Organization (EAPO) | A1 | |
| IL155340D0 | Israel | D0 | |
| BG107802A | Bulgaria | A | |
| US2004058394A1 | United States of America | A1 | |
| JP2004512609A | Japan | A | |
| AR035352A1 | Argentina | A1 | |
| JP2004515848A | Japan | A | |
| JP2004518461A | Japan | A | |
| JP2004524203A | Japan | A | |
| TR200300478T2 | Türkiye | T2 | |
| JP2004532608A | Japan | A | |
| JP2004533732A | Japan | A | |
| CN1547590A | China | A | |
| ZA200303347B | South Africa | B | |
| MXPA03003144A | Mexico | A | |
| PL366307A1 | Poland | A1 | |
| US6909947B2 | United States of America | B2 | |
| US6925425B2 | United States of America | B2 | |
| EP1328857B1 | European Patent Office (EPO) | B1 | |
| EP1328421B1 | European Patent Office (EPO) | B1 | |
| AT312377T | Austria | T | |
| AT313127T | Austria | T | |
| DE60115693D1 | Germany | D1 | |
| DE60115940D1 | Germany | D1 | |
| BR0114646A | Brazil | A | |
| GEP20063752B | Georgia | B | |
| DK1328421T3 | Denmark | T3 | |
| YU28503A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| ES2254526T3 | Spain | T3 | |
| EA006945B1 | Eurasian Patent Organization (EAPO) | B1 | |
| DE60115940T2 | Germany | T2 | |
| ES2256319T3 | Spain | T3 | |
| DE60115693T2 | Germany | T2 | |
| EP1326759B1 | European Patent Office (EPO) | B1 | |
| AT346764T | Austria | T | |
| DE60124937D1 | Germany | D1 | |
| TR200602095T2 | Türkiye | T2 | |
| ES2275748T3 | Spain | T3 | |
| DE60124937T2 | Germany | T2 | |
| AU2002211747B2 | Australia | B2 | |
| EP1326759B8 | European Patent Office (EPO) | B8 | |
| NZ525793A | New Zealand | A | |
| KR100860952B1 | Republic of Korea | B1 | |
| US7429644B2 | United States of America | B2 | |
| JP2008282022A | Japan | A | |
| KR100872000B1 | Republic of Korea | B1 | |
| US2009092601A1 | United States of America | A1 | |
| US7565230B2 | United States of America | B2 | |
| JP4307833B2 | Japan | B2 | |
| KR100943397B1 | Republic of Korea | B1 | |
| EP1330377B1 | European Patent Office (EPO) | B1 | |
| AT500996T | Austria | T | |
| DE60144191D1 | Germany | D1 | |
| EP1330377B8 | European Patent Office (EPO) | B8 |
Numbers
- Publication, DOCDB
- 6779
- Publication, EPODOC
- IS6779
- Application
- 6779
- Application, DOCDB
- 6779
- Application, EPODOC
- IS20030006779
Titles2
- Icelandic
- Mannlíkt mótefni gegn LT-beta-R
- English
- Human antibody to LT-beta-R
Classification
- CPC, 5
- C07K16/2866
- C07K16/28
- A61K2039/505
- C07K2317/24
- A61P35/00
- IPC, 10
- A61K39 395
- A61P35 00
- C07K
- C07K16 28
- C07K19 00
- C12N
- C12N15 09
- C12N5 10
- C12N15 02
- C12N15 13